Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc. financial statements
Brainstorm Cell Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 703K | EODHD |
| Net income | −USD 10.31M | 10-K |
| Cash and equivalents | USD 29K | 10-Q |
| Total debt | USD 208K | EODHD |
Brainstorm Cell Therapeutics Inc. financials on 6ix · Brainstorm Cell Therapeutics Inc. on 6ix